The time is right to invest in proven, highly profitable genetics with wool offering strong returns.
The outstanding commercial performance of Greendale merino genetics is highlighted in recent comparison trials across NSW.
Greendale Merinos benchmark its genetics with other Merino genetics through ASBVs, sire evaluations and wether trials.
The breeder currently has three sires entered in the Merino Lifetime Productivity (MLP) project, evaluating them against other industry sires.
Results to date include:
- Greendale 12-012 Temora 2016 drop ranked 1st FP+ and MP+ index
- Greendale 14-141 Temora 2017 ranked 1st FP+ and MP+ index
- Greendale 15-018 Yass 2017 drop ranked 1st FP+ and 2nd MP+ index
- Greendale 12-012 progeny at Balmoral 2016 drop – highly ranked
At the Peter Westblade Memorial Merino Challenge Wagga 2016-2018, clients using Greendale genetics were ranked first, second and third on dollar return per hectare (as shown in PWMMC wether trial results – wool and liveweight – by NSW DPI sheep development officer Geoff Casburn.
It should be highlighted that in the last 15 years of the Bookham trial, Greendale genetics have produced the highest profit per hectare.
The latest Bookham trial (2015-2018) concluded with Greendale genetics finishing first, while commercial clients Dean and Marcelle Incher of Mayfield Partnership had the highest dollar return per hectare in this trial of 29 teams.
This year Greendale has embarked on the use of genomics with DNA testing of nucleus flock ewes through Merinolink, and partly funded by the University of New England and MLA donor company. This testing will enable the breeder to obtain full pedigree on all of its nucleus flock and achieve greater predictability and accuracy on ASBVs.
Greendale genetics are a commercial entity focused on producing the most efficient and profitable merino.
Greendale genetics will be offered at its annual ram sale on October 25. Lots available include sons of industry-leading sires Hazeldean 11-3542, and Greendale 14-141 and 12-012 and 15-018.